Category: Diagnosis and Treatment Guidelines

Primary Lung Cancer Treatment Guidelines (2022 Edition)     I. Overview Primary lung cancer is the most common malignant tumor in China. From the perspective of pathology and treatment, lung…

Treatment Guidelines for Renal Cell Carcinoma (2022 Edition)     I. Overview Renal cell carcinoma (Renal cell carcinoma, RCC) is a malignant tumor originating from the renal tubular epithelium, accounting…

Thyroid Cancer Treatment Guidelines (2022 Edition) I. Overview   Thyroid cancer is a malignant tumor originating from the follicular epithelium or parafollicular epithelium of the thyroid gland, and is the…

Autoimmune hemolytic anemia guidelines (2022 Edition)   I. Overview Autoimmune Hemolytic Anemia (AIHA) is a condition in which abnormal immune function leads to hyperfunction of B cells producing antibodies to…

Pancreatic Cancer Treatment Guidelines (2022 Edition)     I. Overview In recent years, the incidence of pancreatic cancer has been on a significant rise both at home and abroad. The…

Guidelines for the diagnosis and management of endometrial cancer (2022 Edition)     I. Overview Endometrial cancer is an epithelial malignant tumor that occurs in the endometrium, also known as…

Hemophilia A Guidelines (2022 Edition)   I. Overview Hemophilia A (HA) is an inherited bleeding disorder with X-chromosome linked recessive inheritance. The main clinical manifestation is a qualitative or quantitative…

Glioma Treatment Guidelines (2022 Edition) I. Overview Gliomas are tumors that originate from glial cells in the brain and are the most common primary intracranial tumors. The 2021 edition of…

Diffuse Large B-Cell Lymphoma Guidelines (2022 Edition) I. Overview Diffuse large B cell lymphoma (DLBCL) is an aggressive tumor derived from mature B cells and is the most common type…

Lymphoma Treatment Guidelines (2022 Edition) I. Overview Lymphoma is one of the most common malignant tumors in China. According to the World Health Organization GLOBOCAN 2020, the number of new…